☆ 4.4 Article

An exploratory analysis of clinical and sociodemographic factors in CGRP-induced migraine attacks: A REFORM study

CEPHALALGIA (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics

William Kristian Karlsson et al.

Summary: The REFORM study aims to discover biomarkers that can predict response to erenumab in migraine patients. This article provides a comprehensive description of the study methodology and the baseline characteristics of the study population. Future publications will report the results of the investigations.

JOURNAL OF HEADACHE AND PAIN (2023)

Add to Collection

Article Clinical Neurology

Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura A Secondary Analysis of Randomized Clinical Trials

Messoud Ashina et al.

Summary: The study showed that erenumab treatment reduced migraine frequency and AMSM days in patients with migraine with and without aura. The safety and efficacy of using erenumab in this patient population were supported regardless of aura history.

JAMA NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2

Messoud Ashina et al.

Summary: This subgroup analysis evaluated the efficacy and safety of eptinezumab for migraine prevention in patients with self-reported aura. The results showed that eptinezumab had comparable preventive efficacy for both episodic and chronic migraine patients with aura, with a similarly favorable safety and tolerability profile as the overall study populations.

CEPHALALGIA (2022)

Add to Collection

Article Clinical Neurology

Hypersensitivity to calcitonin gene-related peptide in chronic migraine

Afrim Iljazi et al.

Summary: The study revealed that chronic migraine patients are hypersensitive to calcitonin gene-related peptide, with those experiencing ongoing headache being more likely to develop migraine-like attacks after infusion.

CEPHALALGIA (2021)

Add to Collection

Article Clinical Neurology

Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients

Hashmat Ghanizada et al.

Summary: This study investigated the role of pramlintide in the pathogenesis of migraine, finding that it participates in migraine attacks through activation of the amylin receptor. Through experiments on patients and studies on animal models, it was discovered that pramlintide and CGRP have similar effects in inducing migraine-like symptoms.

ANNALS OF NEUROLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Migraine: integrated approaches to clinical management and emerging treatments

Messoud Ashina et al.

Summary: Migraine is a highly disabling neurological disorder affecting over 1 billion people worldwide. Treatment options include pharmacological and non-pharmacological therapies. Building a personalized treatment plan and exploring emerging mechanism-based treatments are crucial for effective management.

LANCET (2021)

Add to Collection

Article Clinical Neurology

Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine A Randomized Crossover Study

Hashmat Ghanizada et al.

Summary: The study confirms that IV infusion of adrenomedullin may trigger migraine attacks, leading to increased headache intensity and changes in physiological indicators such as heart rate and flushing.

NEUROLOGY (2021)

Add to Collection

Review Clinical Neurology

Diagnosis and management of migraine in ten steps

Anna K. Eigenbrodt et al.

Summary: Migraine is a common but often under-diagnosed and under-treated condition. The Consensus Statement provides guidelines for diagnosis and management, emphasizing the importance of patient education and patient-centered care.

NATURE REVIEWS NEUROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches A Randomized Clinical Trial

Lanfranco Pellesi et al.

Summary: The study found that a 2-hour infusion of VIP caused migraine attacks in 71% of patients, mimicking their spontaneous attacks. Additionally, the area under the curve of headache intensity scores and the superficial temporal artery diameter were significantly greater after VIP compared with placebo infusion.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Clinical Neurology

Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine

Hashmat Ghanizada et al.

Summary: The IV infusion of adrenomedullin was found to increase the incidence and intensity of migraine attacks, as well as significant adverse effects on heart rate and flushing. The study suggests that adrenomedullin may be a potential therapeutic target for migraine treatment.

NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Hypersensitivity to Calcitonin Gene-Related Peptide in Post-Traumatic Headache

Hakan Ashina et al.

ANNALS OF NEUROLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Migraine

Messoud Ashina

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Medicine, General & Internal

Targeting calcitonin gene-related peptide: a new era in migraine therapy

Andrew Charles et al.

LANCET (2019)

Add to Collection

Article Clinical Neurology

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

Jes Olesen

CEPHALALGIA (2018)

Add to Collection

Article Clinical Neurology

Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks A Randomized Clinical Trial

Anne Luise H. Vollesen et al.

JAMA NEUROLOGY (2018)

Add to Collection

Review Physiology

SPREADING DEPRESSION, SPREADING DEPOLARIZATIONS, AND THE CEREBRAL VASCULATURE

Cenk Ayata et al.

PHYSIOLOGICAL REVIEWS (2015)

Add to Collection

Review Clinical Neurology

Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms

Troels S. Jensen et al.

LANCET NEUROLOGY (2014)

Add to Collection

Article Clinical Neurology

Cutaneous allodynia as a predictor of migraine chronification

Mark A. Louter et al.

BRAIN (2013)

Add to Collection

Article Clinical Neurology

Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura

Jakob Moller Hansen et al.

CEPHALALGIA (2010)

Add to Collection

Article Clinical Neurology

PACAP38 induces migraine-like attacks in patients with migraine without aura

Henrik Winther Schytz et al.

BRAIN (2009)

Add to Collection

Review Clinical Neurology

Allodynia in migraine: frequent random association or unavoidable consequence?

Carlo Lovati et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)

Add to Collection

Article Clinical Neurology

Cutaneous allodynia in the migraine population

Richard B. Lipton et al.

ANNALS OF NEUROLOGY (2008)

Add to Collection

Article Clinical Neurology

Defeating migraine pain with triptans: A race against the development of cutaneous allodynia

R Burstein et al.

ANNALS OF NEUROLOGY (2004)

Add to Collection

Article Biochemistry & Molecular Biology

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model

H Bolay et al.

NATURE MEDICINE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.